Author

Roberto Perricone

Tor Vergata - Cited by 7,860

Biography

Roberto Perricone  is currently working at University of Rome Tor Vergata. Roberto Perricone is research interests includes Pharmacy in Molecular Biology. Roberto Perricone serving as an editorial member and reviewer of several international reputed journals. Roberto Perricone has successfully completed his Administrative responsibilities. Roberto Perricone has authored of many research articles/books related to Medicine.
Title
Cited by
Year
The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19
C Perricone, P Triggianese, E Bartoloni, G Cafaro, AF Bonifacio, R Bursi, ...Journal of Autoimmunity 111, 102468, 2020202
153
2020
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study
MS Chimenti, GL Fonti, P Conigliaro, F Sunzini, R Scrivo, L Navarini, ...Expert Opinion on Biological Therapy 20 (7), 813-821, 2020202
36
2020
Intravenous immunoglobulins at the crossroad of autoimmunity and viral infections
C Perricone, P Triggianese, R Bursi, G Cafaro, E Bartoloni, MS Chimenti, ...Microorganisms 9 (1), 121, 2021202
29
2021
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus
R Giacomelli, A Afeltra, E Bartoloni, O Berardicurti, M Bombardieri, ...Autoimmunity Reviews 20 (2), 102738, 2021202
28
2021
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender
P Triggianese, L Novelli, MR Galdiero, MS Chimenti, P Conigliaro, ...Autoimmunity Reviews 19 (8), 1090, 2020202
25
2020
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation?
MS Chimenti, GL Fonti, P Conigliaro, P Triggianese, E Bianciardi, ...Annals of General Psychiatry 20, 1-13, 2021202
18
2021
An update for the clinician on biologics for the treatment of psoriatic arthritis
MS Chimenti, A D’Antonio, P Conigliaro, S Ferrigno, A Vendola, ...Biologics: Targets and Therapy, 53-75, 2020202
18
2020
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study.
GM Guidelli, O Viapiana, N Luciano, M De Santis, N Boffini, L Quartuccio, ...Clinical and Experimental Rheumatology 39 (4), 868-873, 2020202
17
2020
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a …
Retention rates and identification of factors associated with anti-TNFα, anti-IL, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a …L Navarini, L Costa, M Tasso, MS Chimenti, D Currado, GL Fonti, ...Clinical Rheumatology 39, 2663-2670, 2020202
17
2020
Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or …
C Nalli, D Lini, L Andreoli, F Crisafulli, M Fredi, MG Lazzaroni, V Bitsadze, ...Biomedicines 9 (6), 671, 2021202
14
2021
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations
MS Chimenti, C Perricone, A D’Antonio, M Ferraioli, P Conigliaro, ...Frontiers in Genetics 12, 67176, 2021202
9
2021
Combined low-level light therapy and intense pulsed light therapy for the treatment of dry eye in patients with Sjögren’s syndrome
M Di Marino, P Conigliaro, F Aiello, C Valeri, C Giannini, R Mancino, ...Journal of Ophthalmology 2021, 2021202
9
2021
The experience of living with a chronic disease in pediatrics from the mothers’ narratives: The clinical interview on parental sense of grip on the disease
L Savarese, MF Freda, R De Luca Picione, P Dolce, R De Falco, ...Health Psychology Open 7 (2), 2055102920971496, 2020202
8
2020
COVID-19: disCOVering the role of complement system
P Conigliaro, P Triggianese, C Perricone, MS Chimenti, R Perricone, ...Clin Exp Rheumatol 38 (4), 58-91, 2020202
7
2020
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis
L Navarini, D Currado, A Marino, S Di Donato, A Biaggi, F Caso, L Costa, ...Scientific Reports 12 (1), 498, 2022202
7
2022
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: a STROBE-compliant study
P Conigliaro, MS Chimenti, P Triggianese, A D’Antonio, G Sena, N Alfieri, ...Medicine 100 (12), e25122, 2021202
6
2021
Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib
MS Chimenti, P Conigliaro, L Biancone, R PerriconeTherapeutic Advances in Musculoskeletal Disease 13, 1759720X20977777, 2021202
6
2021
Evaluation of retinal microvascular perfusion in hereditary angioedema: a case-control study
P Triggianese, M Cesareo, MD Guarino, P Conigliaro, MS Chimenti, ...Orphanet Journal of Rare Diseases 15, 1-6, 2020202
4
2020
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology
GD Sebastiani, FR Spinelli, E Bartoloni, A Bortoluzzi, E Bozzolo, ...Lupus 0 (8), 12-124, 2021202
3
2021
Real-world evidence of biologic treatments in psoriatic arthritis in Italy: Results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: An …
D Colombo, M Frassi, G Pagano Mariano, E Fusaro, C Lomater, ...BMC rheumatology 6 (1), 57, 0
2
2022

Referred From: https://scholar.google.com/citations?hl=en&user=iR33QwMAAAAJ

Cited by
Citations 7860
h-index 49
i10-index 144
Recommended Journals
Open Access Journals